FMR LLC Boosts Stake in AEON Credit with 66,000-Share Purchase at HK$9.17 Each

Deep News
08/19

Hong Kong stock exchange filings show that on August 13, FMR LLC increased its position in AEON Biopharma (00900) by 66,000 shares, priced at HK$9.1708 per share, totaling approximately HK$605,300.

Following the transaction, FMR LLC's latest shareholding stands at around 41.8891 million shares, lifting its ownership ratio to 10.00% of the company.

This move reflects a strategic adjustment by the investment firm, reinforcing its stake in the credit services provider amid ongoing market activities.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10